Venous thromboembolism (VTE) Treatment Is Advancing, With Growing Awareness among Population Regarding the Condition

Venous thromboembolism (VTE)
Venous thromboembolism (VTE)

Venous thromboembolism (VTE) is a serious medical condition involving blood clots that form in veins and travel throughout the body, often lodging in the lungs. It is often fatal, however, with early diagnosis and treatment it can be treatable. VTE is a common health problem that affects people of all ages and races. It can be triggered by multiple factors and is not always diagnosed until symptoms are present. It can be caused by a genetic or acquired risk factor that is either constant or transient in nature.

Thromboembolism causes life-threatening, long-term complications that include deep vein thrombosis and pulmonary embolism. These conditions can significantly impact a patient’s quality of life and are associated with significant hospital-acquired costs, including readmissions.

In the United States, Venous thromboembolism (VTE) Market is estimated to occur at a rate of approximately 1 per 1,000 person-years in both men and women.

It is the third most common cause of hospital-acquired mortality after cardiovascular disease and stroke, and is largely preventable. Patients with VTE are often treated with anticoagulants that include vitamin K antagonists (VKA) such as warfarin and low-molecular weight heparin. These medications help to break up blood clots and prevent new clots from forming. They can be effective in preventing recurrent venous thromboembolism and pulmonary embolism, however, they can have side effects and can also interact with many other drugs.

The most important step to preventing VTE is knowing the risk. The doctor can find out patient’s risk by asking questions about their medical history, physical activity levels, diet, smoking habits and family history of venous thromboembolism.

Risk factors for DVT and PE are similar among men and women, however, risk for recurrent Venous thromboembolism (VTE) is higher in those with certain medical or surgical conditions. For example, those with venous ulcers are at increased risk of DVT and pulmonary embolism. In December 2021, the U.S. Food and Drug Administration (FDA) granted approval to Xarelto (rivarixaban) as an oral suspension and as tablets for treating venous theromboembolism.

Comments

Post a Comment

Popular posts from this blog

Biopreservation Have Become Important Tool For Bioengineering, Computer Sciences, Molecular Biology, And Cellular Biology

Image
Biopreservation Biopreservation is an increasingly important area of science, spanning fields as diverse as cryobiology, bioengineering, computer sciences, molecular biology, and cellular biology. The field is expanding rapidly in response to new challenges, including stem cell research, personalized medicine, and cancer research. In order to optimize the process for each particular application, it is crucial to evaluate the benefits and drawbacks of various techniques. The processes use natural macrobiotics to enhance food safety and preserve their quality and nutritional content. The most common biopreservatives are produced by lactic acid bacteria, which are antagonistic to most foodborne pathogens. Lactic acid bacteria are able to produce a variety of antimicrobial compounds, including acetic acid and hydrogen peroxide. In addition, some lactic acid bacteria can also produce nisin, a highly effective preservative. Another form of Biopreservation is inoculation, in which natural b...
Read more

Gynecological Cancer Drugs Are Of Different Types and Are Used Depending On the Specific Needs of the Patient

Image
Gynecological Cancer Drugs Recognizing the signs of gynecological cancer is crucial since the symptoms are often vague. It is hence important for women to know what they should be looking for and how to identify the signs of gynecological cancer. The CDC has developed a symptom diary for women to keep track of their symptoms. Women with unusual symptoms should also contact their healthcare provider right away. However, in some cases, women may experience a sudden onset of these symptoms. There are different types of Gynecological Cancer Drugs used in the treatments such as chemotherapy. Several types of immunotherapy are now being studied to combat cancer. These therapies are based on the immune system and use the patient's own immune system to fight the disease. Although not approved for all types of cancer, they are being tested on a larger scale. Moreover, these therapies are still in their early stages, so it may take several years before they can be applied to specific cancer...
Read more

Cancer Biologics Is A Biological Therapy That Is Made By Reproducing, Or Growing, Cells In A Carefully Controlled Laboratory Setting

Image
Cancer Biologics Cancer Biologics are drugs that use a patient’s body to fight the disease or to reduce side effects from other treatments such as chemotherapy and radiation. The word biologics refers to substances made from living organisms or their products and used as diagnostic, preventive or therapeutic agents. Some of the ways these drugs work are to help the immune system recognize and fight cancer cells or to suppress the immune system’s inflammatory response that can cause serious side effects. As more biologic drugs are approved by regulatory bodies for the treatment of cancer, the worldwide Cancer Biologics Market is anticipated to develop significantly over the course of the projected period. Biological therapy may also make it easier for the immune system to kill cancer cells by blocking signals that cancer cells send out to hide from the body’s normal defenses. This type of therapy is a highly active area of cancer research. There are many different types of cancer trea...
Read more